A detailed history of Federated Hermes, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 121,223 shares of BIO stock, worth $38.8 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
121,223
Previous 94,436 28.37%
Holding current value
$38.8 Million
Previous $25.8 Million 57.26%
% of portfolio
0.09%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$263.97 - $344.64 $7.07 Million - $9.23 Million
26,787 Added 28.37%
121,223 $40.6 Million
Q2 2024

Aug 08, 2024

BUY
$268.26 - $339.48 $1.14 Million - $1.44 Million
4,253 Added 4.72%
94,436 $25.8 Million
Q1 2024

May 14, 2024

BUY
$304.11 - $351.99 $3.25 Million - $3.76 Million
10,693 Added 13.45%
90,183 $31.2 Million
Q4 2023

Jan 31, 2024

BUY
$269.37 - $365.04 $4.78 Million - $6.48 Million
17,762 Added 28.77%
79,490 $25.7 Million
Q3 2023

Nov 13, 2023

BUY
$350.25 - $422.63 $5.56 Million - $6.71 Million
15,871 Added 34.61%
61,728 $22.1 Million
Q2 2023

Aug 14, 2023

SELL
$359.49 - $486.4 $842,285 - $1.14 Million
-2,343 Reduced 4.86%
45,857 $17.4 Million
Q1 2023

May 08, 2023

BUY
$418.69 - $503.0 $4.46 Million - $5.36 Million
10,661 Added 28.4%
48,200 $23.1 Million
Q4 2022

Feb 13, 2023

SELL
$351.71 - $456.01 $1.47 Million - $1.91 Million
-4,178 Reduced 10.02%
37,539 $15.8 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $937,404 - $1.28 Million
-2,272 Reduced 5.16%
41,717 $17.4 Million
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $3.39 Million - $4.37 Million
7,318 Added 19.96%
43,989 $21.8 Million
Q1 2022

May 13, 2022

SELL
$524.57 - $735.42 $9.63 Million - $13.5 Million
-18,351 Reduced 33.35%
36,671 $20.7 Million
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $693,245 - $777,197
978 Added 1.81%
55,022 $41.6 Million
Q3 2021

Nov 15, 2021

SELL
$657.71 - $825.77 $481,443 - $604,463
-732 Reduced 1.34%
54,044 $40.3 Million
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $8.82 Million - $9.93 Million
-15,303 Reduced 21.84%
54,776 $35.3 Million
Q1 2021

May 13, 2021

SELL
$547.01 - $662.35 $2.04 Million - $2.47 Million
-3,736 Reduced 5.06%
70,079 $40 Million
Q4 2020

Feb 12, 2021

SELL
$510.68 - $643.45 $1.38 Million - $1.74 Million
-2,706 Reduced 3.54%
73,815 $43 Million
Q3 2020

Nov 12, 2020

SELL
$454.43 - $535.6 $3.75 Million - $4.42 Million
-8,256 Reduced 9.74%
76,521 $39.4 Million
Q2 2020

Aug 13, 2020

SELL
$334.87 - $493.06 $16 Million - $23.5 Million
-47,755 Reduced 36.03%
84,777 $38.3 Million
Q1 2020

May 13, 2020

SELL
$320.01 - $409.07 $6.28 Million - $8.03 Million
-19,631 Reduced 12.9%
132,532 $46.5 Million
Q4 2019

Feb 14, 2020

SELL
$319.73 - $374.2 $8.08 Million - $9.45 Million
-25,266 Reduced 14.24%
152,163 $56.3 Million
Q3 2019

Nov 14, 2019

SELL
$304.55 - $345.24 $1.28 Million - $1.45 Million
-4,212 Reduced 2.32%
177,429 $59 Million
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $1.15 Million - $1.25 Million
-3,995 Reduced 2.15%
181,641 $56.8 Million
Q1 2019

May 10, 2019

SELL
$224.3 - $317.41 $4.91 Million - $6.95 Million
-21,904 Reduced 10.55%
185,636 $56.7 Million
Q4 2018

Feb 13, 2019

SELL
$220.1 - $309.0 $6.61 Million - $9.28 Million
-30,022 Reduced 12.64%
207,540 $48.2 Million
Q3 2018

Nov 13, 2018

BUY
$289.28 - $326.15 $65.6 Million - $73.9 Million
226,667 Added 2080.47%
237,562 $74.4 Million
Q2 2018

Aug 10, 2018

BUY
$244.1 - $303.88 $715,213 - $890,368
2,930 Added 36.79%
10,895 $3.14 Million
Q1 2018

May 09, 2018

SELL
$233.97 - $274.11 $27,842 - $32,619
-119 Reduced 1.47%
7,965 $1.99 Million
Q4 2017

Feb 14, 2018

SELL
$216.94 - $271.3 $258,158 - $322,847
-1,190 Reduced 12.83%
8,084 $0
Q3 2017

Nov 13, 2017

BUY
$212.27 - $242.28 $1.97 Million - $2.25 Million
9,274
9,274 $2.06 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.89B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.